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Thromboelastometry in 
neonates and infants 
undergoing cardiac surgery
ABSTRACT
Introduction. Rotational thromboelastometry (ROTEM) in monitoring coagulation in children undergoing cardiac surgery 
has been studied with promising results. Since the data about ROTEM in infants and neonates undergoing cardiac surgery 
are scarce, the aim of our study was to asses ROTEM abnormalities in this patient group.
Methods. Infants and neonates undergoing cardiac surgery on cardiopulmonary bypass were included in this prospective, 
observational study conducted in a level III multidisciplinary neonatal and pediatric intensive care unit (ICU) between May 
2011 and January 2012. ROTEM analysis, together with determination of platelet count, international normalized ratio of 
prothrombin time (INR), activated partial thromboplastin time (PTT), and fibrinogen concentration, was done in all neonates 
and infants before surgery (t1), after admission to ICU (t2) and 24 hours after surgery (t3).
Results. Twenty infants and neonates were operated on during the time of the study. ROTEM abnormalities seen after sur-
gery (t2) were: thrombocytopenia 14, hypofibrinogenemia 1, mixed hypofibrinogenemia and coagulation factor deficiency 
1, and mixed thrombocytopenia with mild hyperfibrinolysis 1. Three patients were found to have normal ROTEM results. 
The median values of all except one of the ROTEM tests, as well as platelet count, INR, PTT, and fibrinogen concentration, 
showed significant prolongation or deterioration after admission to ICU and these deteriorations persisted in several para-
meters for 24 hours.
Conclusions. In our neonates and infants, cardiac surgery on cardiopulmonary bypass predominantly affects platelets, 
although most of the ROTEM parameters deteriorated after admission to ICU. 
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Introduction
Rotat iona l  Thromboelastometry 
(ROTEM) graphically represents the 
fibrin polymerization process in a throm-
boelastogram and provides a complete 
evaluation of the process of clot ini-
tiation, formation, and stability. (1) The 
original one-trace ROTEM was recently 
upgraded with the addition of new dif-
ferent coagulation-inducing agents 
and platelet-inhibiting agents, which 
allow detection of specific coagulation 
defects like hypofibrinogenemia, factor 
deficiency, thrombocytopenia, heparin 
influence and hyperfibrinolysis. (2,3)
The causes of bleeding in patients 
undergoing cardiac surgery on cardiop-
ulmonary bypass are multifactorial, and 
involve hemodilution, anticoagulation 
(heparin), activation of coagulation and 
fibrinolytic systems and impairment of 
platelet function. (4) ROTEM provides a 
tool to specifically asses some of these 
changes and furthermore, it is a faster 
method than standard laboratory tests 
of coagulation. (5,6) First results with 
ROTEM can be obtained within 10-30 
minutes. (1,7) ROTEM has already been 
successfully used as a point of care 
test in adult cardiac surgery (2,8,9) and 
there is growing evidence of its use-
fulness in paediatric cardiac surgery. 
(4,7,10-12) Since the coagulation sys-
tem in infants and neonates has some 
unique characteristics (4,13,14) and 
the data about thromboelastometry in 
infants and neonates after cardiac sur-
gery are scarce, we decided to asses 
ROTEM abnormalities in neonates and 
infants undergoing cardiac surgery.
Methods
Infants and neonates undergoing cardi-
ac surgery on cardiopulmonary bypass 
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between May 2011 and January 2012, 
and postoperatively admitted to a level 
III, multidisciplinary neonatal and pae-
diatric intensive care unit (ICU), were 
included in this prospective, obser-
vational study. Infants and neonates 
with previously known coagulopathies 
or thrombocytopathies were exclud-
ed from the study. The study proto-
col encompassing patient data and 
surgery data was completed for each 
patient. Administration of blood prod-
ucts and the amount of bleeding were 
recorded hourly during the first 24h.
Blood samples for ROTEM® analysis 
were obtained before surgery (t1), after 
admission to ICU (t2) and 24 hours 
after surgery (t3) together with platelet 
count, international normalized ratio 
of prothrombin time (INR), activated 
partial thromboplastin time (PTT), and 
fibrinogen concentration. Whole blood 
citrate-anticoagulated samples (1.8 
mL) were immediately transported to 
the central hospital laboratory, where 
ROTEM analysis by Rotem delta ana-
lyzer (Penthapharm GmbH) was per-
formed. ROTEM analysis was done 
by measuring clotting time (CT), clot 
formation time (CFT), maximum clot 
firmness (MCF), and maximum lysis 
(ML). Separate analyses were per-
formed for EXTEM (extrinsic screen-
ing test), INTEM (intrinsic screening 
test), FIBTEM (fibrinogen screening 
test), HEPTEM (heparin screening test) 
and APTEM (hyperfibrinolysis screen-
ing test). Each test required 300 L 
of citrate-anticoagulated whole blood. 
The sample preparation and Rotem 
analyzer setup were based on the man-
ufacturer’s instructions.
Data were presented as the median 
and range. The Mann-Whitney U test 
was used to compare ROTEM parame-
ters for different time points (t1 vs. t2, t1 
vs. t3) and between groups (neonates 
younger than 29 days versus infants 
older than 28 days; and infants receiv-
ing continuous infusion of prostaglan-
din E1 (PGE1) before surgery vs. infants 
without PGE1 infusion). Differences 
were considered to be statistically sig-
nificant at a level of P <0.05. Statistical 
analysis was performed using SPSS 
for Windows, version 12.0 (SPSS INC., 
Chicago, IL, USA).
The study was approved by the Nation-
al Medical Ethics Committee of the Min-
istry of Health, Republic of Slovenia, 
and written consent was obtained from 
parents before blood sampling. 
Results
Twenty infants and neonates were oper-
ated on during the time of the study. The 






Number of neonates (<29 days) 9
Number of infants on prostaglandin E1 7
Age
Median (range) 103 days (9-302 days)
Diagnoses
Ventricular septal defect
d-Transposition of great arteries (arterial switch)
Truncus arteriosus
Aortopulmonary window
Pulmonary atresia (BT shunt and unifocalization or PA repair)
Atrioventricular canal
Tetralogy of Fallot (total repair)
Double outlet right ventricle












Median time of cardiopulmonary bypass 98 min (60-217 min)
Median time of circulatory arrest 73 min (0-118 min)
Median time of hypothermia <32ºC 48 min (0-170 min)
Median postoperative blood loss in first hour 9 mL/kg (0.7-36 mL/kg)
Median postoperative blood loss in first 24h 34 mL/kg (10-160 mL/kg)
No of patients receiving blood products in ICU






Median packed red blood cells in ICU in first 24h 29 mL/kg (0-149 mL/kg)
Median fresh frozen plasma in ICU in first 24h 29 mL/kg (0-99 mL/kg)
Median packed platelets in ICU in first 24h 0 mL/kg (0-36 mL/kg)
Deaths 1
BT, Blalock-Taussig; ICU, intensive care unit; PA, pulmonary artery.
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patients’ characteristics are summarized 
in table 1. None of the operated infants 
and neonates had known coagulopathy 
or thrombocytopathy. No surgical reex-
plorations due to postoperative bleed-
ing were needed. One patient died on 
the fifth postoperative day. The majority 
of patients received packed red blood 
cells and fresh frozen plasma (table 1), 6 
patients received packed platelets and 2 
patients received fibrinogen concentrate 
in ICU. No prothrombin complex con-
centrate or activated factor VII were given 
in ICU. According to the ROTEM analy-
sis after admission to ICU (t2) patients 
were classified into one of the following 
groups: thrombocytopenia 14, hypofi-
brinogenemia 1, mixed hypofibrinogen-
emia and coagulation factor deficiency 
1, and mixed thrombocytopenia with 
mild hyperfibrinolysis 1. Three patients 
showed normal ROTEM results. The 
median values of all except one of the 
ROTEM tests, as well as platelet count, 
INR, PTT, and fibrinogen concentration, 
showed significant prolongation or dete-
rioration after surgery, and these deterio-
rations persisted for several parameters 
over the  next 24h (table 2). 
Median EXTEM-CT, FIBTEM-CT, and 
APTEM-CT before surgery (t1) and 24 h 
after surgery (t3) were shortened in our 
patients in comparison to our hospital 
laboratory reference values. The prolon-
gation of median INTEM-CFT and HEP-
TEM CFT was recorded after admission 
to ICU (t2), as well as a decrease of 
EXTEM-MCF, INTEM-MCF, APTEM-
MCF, and HEPTEM-MCF, in compari-
son to our hospital laboratory reference 
values. HEPTEM-MCF was the only 
value that dropped 24h after surgery 
(t3) in comparison to our hospital labo-
ratory reference values (table 2). 
The following laboratory tests differ-
entiated between neonates younger 
than 29 days and infants older than 28 
days: before surgery (t1): HEPTEM-CT 
(median 140 s vs. median 105 s; Mann-
Whitney U test, P = 0.040); 24 hours 
after surgery (t3): EXTEM-CT (median 
25 s vs. median 35 s; Mann-Whitney 
U test, P = 0.014); EXTEM-ML(median 
1% vs. median 5%; Mann-Whitney U 
test, P = 0.029); INTEM-CT (median 
136 s vs. median 164 s; Mann-Whitney 
U test, P = 0.012); APTEM-ML (median 
0% vs. median 3%; Mann-Whitney U 
test, P = 0.02); HEPTEM-ML (median 
0.5% vs. median 2%; Mann-Whitney U 
Table 2.  Median values and ranges of platelet count (x109/L), INR, PTT, fibrinogen concentration (g/L) and ROTEM 
parameters, before surgery (t1), after admission to the intensive care unit (t2) and 24h after surgery (t3). The 
median values outside our hospital laboratory reference values are in bold. 








Platelet count 393 (137-742) 112 (33-261) 147 (79-270) 0.0000* 0.0000*
INR 1.06 (0.97-1.25) 1.33 (1.06-2.77) 1.23 (1.06–2.40) 0.0000* 0.0002*
PTT 33 s (26-41) 37 s (19-67) 38 s (27-61) 0.0053* 0.0599
Fibrinogen 2.25 (1.8-3.31) 1.76 (0.7-2.44) 2.48 (0.50-3.16) 0,0001* 0,4175
EXTEM-CT 25 s (7-47) 36 s (22-144) 27 s (13-43) 0.0001* 0.1131
EXTEM-CFT 70 s (33-103) 155 s (54-500) 110 s (69-155) 0.0000* 0.0001*
EXTEM-MCF 63 mm (52-79) 48 mm (29-64) 57 mm (45-62) 0.0000* 0.0001*
EXTEM-ML 3% (0-10) 0% (0-13) 3% (0-14) 0.0089* 0.9342
INTEM-CT 144 s (14-242) 186 s (128-330) 150 s (122-200) 0.0009* 0.2834
INTEM-CFT 59 s (32-90) 143 s (74-538) 83 s (54-181) 0.0000* 0.0001*
INTEM-MCF 63 mm (48-77) 48 mm(28-56) 55 mm (45-64) 0.0000* 0.0001*
INTEM-ML 2% (0-9) 0% (0-8) 3% (0-14) 0.0253* 0.6089
FIBTEM-CT 21 s (15-41) 35 s (15-59) 30 s (3-46) 0.0005* 0.0087*
FIBTEM-MCF 17 mm (11-50) 11 mm (5-49) 18 mm (12-24) 0.0003* 0.9176
FIBTEM-ML 3% (0-33) 3% (0-18) 1% (0-8) 0.7148 0.4478
APTEM-CT 23 s (5-43) 40 s (13-65) 34 s (22-47) 0.0003* 0.0002*
APTEM-CFT 68 s (35-124) 158 s (87-771) 99 s (67-183) 0.0000* 0.0045*
APTEM-MCF 62 mm (49-79) 47 mm (26-81) 57 mm (43-61) 0.0000* 0.0003*
APTEM-ML 1% (0-10) 0% (0-4) 1% (0-11) 0.0174* 0.7048
HEPTEM-CT 126 s (33-178) 165 s (121-316) 129 s (50-311) 0.0010* 0.6637
HEPTEM-CFT 61 s (33-117) 154 s (90-653) 106 s (67-234) 0.0000* 0.0001*
HEPTEM-MCF 61 mm (46-76) 44 mm (27-52) 48 mm (39-57) 0.0000* 0.0003*
HEPTEM-ML 2% (0-7) 0% (0-12) 1% (0-12) 0.0370* 0.5016
APTEM, hyperfibrinolysis screening test; CFT, clot formation time; CT, clotting time; EXTEM, extrinsic screening test; FIBTEM, fibrinogen 
screening test; HEPTEM, heparin screening test; INR, international normalized ratio of prothrombin time; INTEM, intrinsic screening test; MCF, 
maximum clot firmness; ML, maximum lysis; PTT, activated partial thromboplastin time; ROTEM, Rotational thromboelastometry.
* – statistically significant p values (p <0.05)
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test, P = 0.03). Duration of hypothermia 
(below 32ºC) was longer in neonates, 
and neonates received more fresh 
frozen plasma than infants, although 
differences did not reach statistical sig-
nificance (median 68 min vs. median 0 
min; Mann-Whitney U test, P = 0.054; 
and median 48 mL vs. median 15 mL; 
Mann-Whitney U test, P = 0.062). No dif-
ferences were found between neonates 
and infants for platelet count, INR, PTT, 
fibrinogen concentration, time of car-
diopulmonary bypass and circulatory 
arrest, postoperative blood loss in the 
first hour and in the first 24h, and vol-
ume of transfused packed red blood 
cells (Mann-Whitney U test, P >0.1 for 
all comparisons). The only laboratory 
test that differentiated between infants 
receiving PGE1 and infants without 
PGE1 was EXTEM-CT 24h following 
surgery (median 24 s vs. median 34 s; 
Mann-Whitney U test, P = 0.023). 
Discussion
Cardiac surgery on cardiopulmonary 
bypass can affect different aspects of 
coagulation. (15-17) Although most of 
the ROTEM parameters showed sig-
nificant deterioration following surgery, 
thrombocytopenia was the predominant 
ROTEM abnormality seen in our group 
of neonates and infants.
Straub et al. found in 10 infants undergo-
ing cardiac surgery on cardiopulmonary 
bypass prolongation of CT in INTEM 
and HEPTEM and a decrease in INTEM, 
HEPTEM, EXTEM and FIBTEM ampli-
tude which represented a measure for 
clot firmness and is similar to our MCF. 
(7) The authors concluded that these 
changes reflected the defect in plas-
matic coagulation together with platelet 
damage. (7) In our group of patients CT 
was significantly prolonged after admis-
sion to ICU (t2) in comparison to base-
line (t1), but the median CT result in 
all ROTEM tests was still within normal 
range according to our reference values. 
This shows that a plasmatic coagula-
tion defect was not the most important 
cause of bleeding in our patients. Mean-
while, prolongation of median CFT in 
INTEM and HEPTEM, when compared 
to our reference values, together with 
reduction of median MCF in all ROTEM 
tests except FIBTEM, were found in our 
patients after admission to ICU (t2). In 
addition, significant prolongation of CFT 
and reduction of MCF in all ROTEM 
tests were found in our patients after 
admission to ICU (t2). Since CFT and 
MCF, except from factor XIII, are mainly 
based on platelets and fibrinogen, and 
furthermore, fibrinogen dysfunction can 
be excluded with FIBTEM-MCF in the 
normal range, we concluded that the 
most important cause of bleeding in our 
patients was thrombocytopenia. This 
finding was also supported by lowered 
median platelet count after surgery (t2). 
However, we cannot exclude the influ-
ence of lower fibrinogen concentration 
after surgery (t2) on the drop in MCF in 
EXTEM, INTEM, HEPTEM and APTEM. 
According to the ROTEM results, there 
was only one case of mild hyperfibrinoly-
sis and two cases of hypofibrinogen-
emia in our patients.
Tirosh-Wagner et al. found a significant 
increase in CT and a decrease in MCF in 
15 children undergoing cardiac surgery 
24h after surgery. (4) Unfortunately, the 
authors did not compare the values to 
their references values. Median postop-
erative loss in their study (4), in the first 
24h, was very similar to ours, but they 
used far less blood products than we 
did. We used fresh frozen plasma in the 
majority of our patients, which explains 
the return of CT toward baseline values 
(t1) in our patients 24h after surgery (t3), 
despite bleeding. 
Hayashi et al. found no significant 
changes in ROTEM tests 24h after car-
diac surgery in 21 children, but ROTEM 
analysis in their study was not done 
immediately after surgery. (11) Interest-
ingly, only four children received fresh 
frozen plasma and only two children 
received red cell transfusion within 24h 
after surgery in their study, (11) but chil-
dren in their study were comparatively 
older and the surgical procedures were 
different than the ones in our patients.
Comparison of ROTEM tests between 
neonates and older infants showed pro-
longed HEPTEM-CT in neonates before 
surgery (t1), but median HEPTEM-CT 
was still in the range of our adults’ refer-
ences values. Interestingly, 24h after 
surgery (t3) neonates showed shorter 
EXTEM-CT, and INTEM-CT, and less 
fibrinolysis than infants. These differenc-
es could be partly explained by more 
fresh frozen plasma being given to our 
neonates, but a similar “hypercoagu-
lability state” in 1-3 month old infants 
has already been described by other 
authors. (18) Recently, age-related ref-
erence values in children in comparison 
to reference ranges in adults were pub-
lished. (14) According to these refer-
ence values, CT values in EXTEM but 
not in INTEM are slightly shorter in 1-3 
month old infants, than in older infants. 
(14) Since our adult reference ranges 
differ from their values, (14) these values 
cannot be absolutely compared to our 
values. The reason is inter-laboratory 
variation of ROTEM tests. 
Although PGE1 can have an inhibitory 
effect on platelet aggregation, (19) we 
found no differences between infants 
receiving PGE1 and those without PGE1 
before surgery (t1) and after admission 
to ICU (t2). Since platelet function can-
not be measured by ROTEM, the spe-
cific tests for platelet function should be 
used to measure the influence of PGE1 
on platelets. (20) Shortened EXTEM-CT 
in infants receiving PGE1 24h after sur-
gery (t3) can be explained by the com-
paratively younger age of infants receiv-
ing PGE1 and by the already described 
“hypercoagulability state” in the first 
three months of life. (14,18)
In conclusion, cardiac surgery on car-
diopulmonary bypass in our neonates 
and infants predominantly affected 
platelets, although most of the ROTEM 
parameters deteriorated. ROTEM might 
be especially useful in evaluation of 
neonates and infants after cardiac sur-
gery on cardiopulmonary bypass, who 
bleed excessively and in whom stand-
ard therapy in our ICU (packed red 




1. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81-90.
2. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thrombo-
elastometry in a cardiac intensive care unit. Transfus Med 2006;16:31-9.
3. Lang T, Bauters A, Braun SL, Pötzsch B, von Pape KW, Kolde HJ, et al. Multi-centre investigation on reference ranges for ROTEM throm-
boelastometry. Blood Coagul Fibrinolysis 2005;16:301-10.
4. Tirosh-Wagner T, Strauss T, Rubinshtein M, Tamarin I, Mishaly D, Paret G, et al. Point of care testing in children undergoing cardiopulmo-
nary bypass. Pediatr Blood Cancer 2011;56:794-8.
5. Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, et al. Comparison of thromboelastometry (ROTEM®) with standard 
plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012;108:36-41.
6. Ogawa S, Szlam F, Chen EP, Nishimura T, Kim H, Roback JD, et al. A comparative evaluation of rotation thromboelastometry and standard 
coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012;52:14-22. 
7. Straub A, Schiebold D, Wendel HP, Hamilton C, Wagner T, Schmid E, et al. Using reagent-supported thromboelastometry (ROTEM) 
to monitor haemostatic changes in congenital heart surgery employing deep hypothermic circulatory arrest. Eur J Cardiothorac Surg 
2008;34:641-7. 
8. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, et al; EACTS Audit and Guidelines Committee. Guideline on antiplatelet 
and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008;34:73-92.
9. Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, et al. Detection of protamine and heparin after termination of 
cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Anesth Analg 2009;108:743-50.
10. Andreasen JB, Hvas AM, Christiansen K, Ravn HB. Can RoTEM® analysis be applied for haemostatic monitoring in paediatric congenital 
heart surgery? Cardiol Young 2011;21:684-91.
11. Hayashi T, Sakurai Y, Fukuda K, Yada K, Ogiwara K, Matsumoto T, et al. Correlations between global clotting function tests, duration of 
operation, and postoperative chest tube drainage in pediatric cardiac surgery. Paediatr Anaesth 2011;21:865-71. 
12. Groselj-Grenc M, Kalan G, Melkic E. Thromboelastometry for detection of specific coagulation defects in children after cardiac surgery – a 
pilot study. The Pediatric Cardiac Intensive Care Society European Conference & Annual Scientific Meeting of PICS (UK). Programme & 
Abstract Book. Cambridge, UK. 2011 Sep 21-23; p. 30.
13. Strauss T, Levy-Shraga Y, Ravid B, Schushan-Eisen I, Maayan-Metzger A, Kuint J, et al. Clot formation of neonates tested by thromboe-
lastography correlates with gestational age. Thromb Haemost 2010;103:344-50. 
14. Oswald E, Stalzer B, Heitz E, Weiss M, Schmugge M, Strasak A, et al. Thromboelastometry (ROTEM) in children: age-related reference 
ranges and correlations with standard coagulation tests. Br J Anaesth 2010;105:827-35.
15. Arnold P. Treatment and monitoring of coagulation abnormalities in children undergoing heart surgery. Paediatr Anaesth 2011;21:494-
503.
16. Besser MW, Klein AA. The coagulopathy of cardiopulmonary bypass. Crit Rev Clin Lab Sci 2010;47:197-212. 
17. Jaggers J, Lawson JH. Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies. Ann Thorac Surg 
2006;81:S2360-6.
18. Haizinger B, Gombotz H, Rehak P, Geiselseder G, Mair R. Activated thrombelastogram in neonates and infants with complex congenital 
heart disease in comparison with healthy children. Br J Anaesth 2006;97:545-52.
19. Koga T, Az-ma T, Yuge O. Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction 
with endothelial cells Acta Anaesthesiol Scand 2002;46:987-93.
20. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole 
blood. Thromb Haemost 2006;96:781-8.
